Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Immunotactoid glomerulopathy (ITG) is a very rare condition characterized by glomerular accumulation of microtubules in the mesangium and the glomerular basement membrane, that mainly presents with proteinuria, micro-hematuria, nephrotic syndrome, renal insufficiency and hematologic malignancy. ITG and non-amyloid fibrillary glomerulopathy (non-amyloid FGP) are often grouped together as pathogenetically related diseases.
Biomarker and diagnostic research for immunotactoid glomerulopathy has been reported in the published literature.
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
71 publications have been identified in PubMed for immunotactoid glomerulopathy. Research spans Case Report / Case Series (68%), Review / Meta-Analysis (15%), and Gene Therapy / Novel Therapeutics (6%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 48 | 68% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 11:54 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
11 |
15% |
New treatment approaches | 4 | 6% |
Testing and diagnosis research | 3 | 4% |
Disease patterns and progression | 3 | 4% |
Clinical study results | 1 | 1% |
Laboratory research | 1 | 1% |
Ebrahimi N (2026). [PMID: 42153899](https://pubmed.ncbi.nlm.nih.gov/42153899/). *J Nephrol*. [Case Report / Case Series]
Fernández-Lorente L (2026). [PMID: 41584267](https://pubmed.ncbi.nlm.nih.gov/41584267/). *Kidney international reports*. [Case Report / Case Series]
Tatis E (2026). [PMID: 41680000](https://pubmed.ncbi.nlm.nih.gov/41680000/). *Nefrologia*. [Gene Therapy / Novel Therapeutics]
Ayehu G (2026). [PMID: 41623306](https://pubmed.ncbi.nlm.nih.gov/41623306/). *Kidney medicine*. [Case Report / Case Series]
Watanabe H (2026). [PMID: 41571866](https://pubmed.ncbi.nlm.nih.gov/41571866/). *CEN case reports*. [Case Report / Case Series]
Vakiti A (2026). [PMID: 29763127](https://pubmed.ncbi.nlm.nih.gov/29763127/). *Unknown Journal*. [Review / Meta-Analysis]
Inoue M (2026). [PMID: 41909296](https://pubmed.ncbi.nlm.nih.gov/41909296/). *Cureus*. [Case Report / Case Series]
Ahmed S (2026). [PMID: 41884769](https://pubmed.ncbi.nlm.nih.gov/41884769/). *Kidney Med*. [Case Report / Case Series]
Sethi S (2026). [PMID: 41895686](https://pubmed.ncbi.nlm.nih.gov/41895686/). *Kidney Int*. [Review / Meta-Analysis]
Lin JY (2026). [PMID: 42021711](https://pubmed.ncbi.nlm.nih.gov/42021711/). *Clin Nephrol*. [Case Report / Case Series]